Previous 10 | Next 10 |
2023-10-17 08:44:34 ET More on Champions Oncology Seeking Alpha’s Quant Rating on Champions Oncology Historical earnings data for Champions Oncology For further details see: Champions Oncology announces addition of Brady Davis as president
HACKENSACK, NJ / ACCESSWIRE / October 17, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, has appointed Brady Davis as President to continue to develop new strategic initiatives to drive accele...
2023-09-15 13:34:03 ET Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Conference Call September 13, 2023, 04:30 PM ET Company Participants Ronnie Morris - CEO David Miller - CFO Conference Call Participants Matt Hewitt - Craig-Hallum David Baron - B...
2023-09-14 01:29:58 ET More on Champions Oncology Seeking Alpha’s Quant Rating on Champions Oncology Historical earnings data for Champions Oncology Financial information for Champions Oncology For further details see: Champions Oncology Non-GAAP E...
HACKENSACK, NJ / ACCESSWIRE / September 13, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, today announced its financial results for its first quarte...
HACKENSACK, NJ / ACCESSWIRE / September 11, 2023 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the first q...
HACKENSACK, NJ / ACCESSWIRE / August 22, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, kicks-off its annual series of events by hosting a scientific symposium at the Museum of Science, in Bos...
HACKENSACK, NJ / ACCESSWIRE / August 1, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions, today announced an agreement to adopt BioVolume's leading 3D imaging and thermal technolo...
2023-07-24 18:34:09 ET Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Conference Call July 24, 2023, 04:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Officer Conference Call Participants Matt Hewitt...
2023-07-24 16:15:39 ET Champions Oncology press release ( NASDAQ: CSBR ): Q4 Non-GAAP EPS of -$0.17 misses by $0.02 . Revenue of $13.1M (+1.6% Y/Y) beats by $0.24M . For further details see: Champions Oncology Non-GAAP EPS of -$0.17 misses by $0.02, reven...
News, Short Squeeze, Breakout and More Instantly...
Champions Oncology Inc. Company Name:
CSBR Stock Symbol:
NASDAQ Market:
Champions Oncology Inc. Website:
HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult (MDC), enhancing their combined capabilities in the expanding f...
HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2024, ended January 31, 2024. Thi...
HACKENSACK, NJ / ACCESSWIRE / March 7, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, announced that the College of American Pathologists (CAP) has awarded accreditation to its US-based labora...